文献速递系统性红斑狼疮

长期伏环孢素治疗对活动性狼疮肾炎患者重复肾活检肾脏组织学的影响

Effect of Long-Term Voclosporin Treatment on Renal Histology in Patients With Active Lupus Nephritis With Repeat Renal Biopsies.
PubMed 文献 · Arthritis Rheumatol · 2025-07-17

AURORA临床试验中,16例伏环孢素组和10例对照组患者完成基线与约18个月后重复肾活检。伏环孢素组多数患者慢性指数无变化或变化不超过2,未见血管或小管病变趋势,组织病理学评估未显示肾毒性。

要点

  • 伏环孢素组16例、对照组10例完成基线与约18个月重复肾活检。
  • 伏环孢素组慢性指数无变化8例、变化不超过2者6例;对照组分别为3例和6例。
  • 组织病理学评估未显示伏环孢素相关肾毒性。

核心结论

  • 小样本亚组结果显示,研究治疗暴露约18个月后组织病理学评估未显示肾毒性。
  • 这些数据令人安心,进一步支持伏环孢素治疗成人活动性狼疮肾炎的安全性。

研究设计与样本

  • AURORA临床试验中,患者随机接受伏环孢素或安慰剂治疗最长3年,所有患者均接受吗替麦考酚酯和低剂量糖皮质激素。
  • 患者在研究开始前6个月内行基线肾活检,并在研究治疗约18个月后行重复肾活检。

主要发现

  • 伏环孢素组16例和对照组10例患者均有基线和重复肾活检,基线临床特征相似。
  • 伏环孢素组多数患者(n=13)为纯IV型病变(纯V型n=1,混合型n=2);对照组纯IV型3例(纯III型n=3,纯V型n=1,混合型n=3)。
  • 伏环孢素组多数患者慢性指数无变化(n=8)或变化不超过2(n=6);对照组慢性指数无变化(n=3)或变化不超过2(n=6)。
  • 未观察到血管病变或小管间室变化的趋势。

关键数值与推荐

  • 采用修订版美国国立卫生研究院指数评估狼疮肾炎活动性和慢性指数,并对血管和小管病变进行半定量评估。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文称该分析为小样本亚组。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study characterized the impact of voclosporin on kidney histology in patients with lupus nephritis (LN) who had protocolized repeat kidney biopsies in the AURORA clinical trials. METHODS: Patients were randomized to voclosporin or placebo treatment for up to 3 years; all patients received mycophenolate mofetil and low-dose glucocorticoids. Patients had baseline kidney biopsies within 6 months before study start and repeat biopsies after approximately 18 months of study treatment. The revised National Institutes of Health indices for LN activity and chronicity (CI) were calculated in addition to a semiquantitative assessment of vascular and tubular lesions. RESULTS: Sixteen patients in the voclosporin group and 10 patients in the control group had both baseline and repeat kidney biopsies. Patient clinical characteristics were similar at baseline. In the voclosporin group, most (n = 13) patients had pure class IV lesions (pure class V, n = 1; mixed, n = 2). In the control group, three patients had pure class IV (pure class III, n = 3; pure class V, n = 1; mixed, n = 3). Most of the voclosporin-treated patients had no change in CI (n = 8) or a change no greater than 2 (n = 6); control-treated patients also had no change in CI (n = 3) or a change no greater than 2 (n = 6). No trends in vascular lesions or tubular compartment changes were observed. CONCLUSION: Outcomes from this small subgroup show that exposure to study treatment was not associated with nephrotoxicity based on histopathologic evaluation after 18 months. These data are reassuring and further contribute to the safety profile of voclosporin for the treatment of adults with active LN.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Rovin BH, Cassol C, Parikh SV, et al. Effect of Long-Term Voclosporin Treatment on Renal Histology in Patients With Active Lupus Nephritis With Repeat Renal Biopsies. Arthritis Rheumatol. 2025. PMID: 40317902. doi:10.1002/art.43209

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。